Abstract:Abstract BackgroundNon-steroidal anti-inflammatory drugs (NSAIDs) are the world's most used drugs with anti-inflammatory, analgesic and antipyretic effects. 2-arylpropionate drugs are a very important class of chiral drugs in NSAIDs. In the pharmaceutical industry, there is an increasing demand for esterase-mediated chiral resolution of racemic 2-arylpropionate esters due to the high activity and low side effects of the (S)-enantiomers. Esterases are important biocatalysts for chemical synthesis owing to their enantioselectivity, regioselectivity, broad substrate specificity and no need for cofactors. Several bHSL family esterases have been used to resolve racemic 2-arylpropionates. However, each reported enzyme was able to synthesize only one NSAIDs drug, which does not meet the industry requirement for catalysts and limits their application.ResultsThrough careful analysis of the structural information and molecular docking, we present the discovery of key residues that controlled the enantioselectivity of bHSL carboxylesterases to ethyl 2-arylpropionates. Est924 was identified as a bHSL family esterase and a promising catalyst for kinetic resolution of racemic ethyl 2-arylpropionates with sight (R)-stereopreference. Using Est924 as the starting enzyme, protein engineering at these key residues was conducted, and the substitution of A203 was shown to affect the enantioselectivity. The stereopreference of the mutant M1(A203W) was inverted to ethyl 2-(S)-arylpropionates, and this stereopreference was further improved in variant M3(I202F/A203W/G208F). In addition, the optimal variant, M3, was also suitable for the resolution of ibuprofen ethyl ester and ketoprofen ethyl ester, and their efficient (S)-isomers were synthesized.ConclusionsOur results suggested that Est924 variants could kinetically resolve economically important racemates for industrial production and further offer the opportunity for the rational design of enzyme enantioselectivity.

Chemoenzymatic Synthesis of (R)- and (S)-Propranolol Using an Engineered Epoxide Hydrolase with A High Turnover Number

[Stereoselective Determination of Propranolol Enantiomer in Transgenic Cell Lines Expressing Human Cytochrome P450].

Chiral separation of propranolol hydrochloride through an SNM process integrated with crystallization

Chiral separation of propranolol hydrochloride by smb process integrated with crystallization

Engineering of an Epoxide Hydrolase for Efficient Bioresolution of Bulky Pharmaco Substrates

Synthesis of Enantiopure (S)-Atenolol by Utilization of Lipase-Catalyzed Kinetic Resolution of a Key Intermediate

Preparing Β-Blocker (R)-Nifenalol Based on Enantioconvergent Synthesis of (R)-P-nitrophenylglycols in Continuous Packed Bed Reactor with Epoxide Hydrolase

Synthesis, Chiral Resolution and Enantiomers Absolute Configuration of 4-Nitropropranolol and 7-Nitropropranolol

Development of an Efficient and Scalable Biocatalytic Route to (1S,4r)-8-hydroxy-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl Propionate Via Enantioselective Enzymatic Desymmetrization of a Prochiral Diester

Improved Enantioselectivity of E. Coli BioH in Kinetic Resolution of Methyl (S)-3-cyclohexene-1-carboxylate by Combinatorial Modulation of Steric and Aromatic Interactions

Protein Engineering for Enhanced Enantioselectivity of Carboxylesterase Est924 Toward Ethyl 2-Arylpropionates

Development of a continuous flow synthesis of propranolol: tackling a competitive side reaction

Biocatalytic resolution of nitro-substituted phenoxypropylene oxides with Trichosporon loubierii epoxide hydrolase and prediction of their enantiopurity variation with reaction time

Chemoenzymatic Asymmetric Synthesis of Chiral Triazole Fungicide (R)-Tebuconazole in High Optical Purity Mediated by an Epoxide Hydrolase from Rhodotorula paludigensis

Enhanced Production of (S)-2-arylpropionic Acids by Protein Engineering and Whole-Cell Catalysis

Chemo-enzymatic Asymmetric Synthesis of S-citalopram by Lipase-Catalyzed Cyclic Resolution and Stereoinversion of Quaternary Stereogenic Center.

Biocatalytic Stereoselective Synthesis of Chiral Precursors for Liposoluble β1 Receptor Blocker Nebivolol

3-Nitroatenolol: First Synthesis, Chiral Resolution and Enantiomers' Absolute Configuration

Controllable selective enzymatic synthesis of N-acyl and O-acylpropranolol vinyl esters and preparation of polymeric prodrug of propranolol

Enantioselective synthesis of (S)-timolol by using chiral C-3 synthons

Chiral Drug-Catalyzed Asymmetric alpha-Hydroxylation of beta-Keto Esters